Following the initial impact of the COVID-19 pandemic, the Canadian market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent grafts.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for Aortic Repair Devices in Canada across a 10-year period.

The aortic repair device market will be affected by the COVID-19 crisis.

How will the COVID-19 outbreak affect the aortic repair device market? 

How quickly are procedure volumes expected to recover?

Aortic repair can be performed using endovascular, surgical or hybrid procedures.

To what extent are hybrid aortic repair procedures being performed for aortic arch and thoracoabdominal indications in Canada?

How will off-the-shelf branched devices for the aortic arch effect the Canadian market?

Which indication has the highest endovascular penetration in Canada?

How are aneurysms at the iliac-branch treated in Canada?

Manufacturers in Canada compete for hospital tender contracts

How has this practice affected the Canadian aortic competitive landscape?

Which competitors gain the most from this competitive landscape?

To what degree will price competition to win contracts affect the market overall?

Table of contents

  • Aortic Repair Devices - Market Insights - Canada

Author(s): Siva Kumar Pulla, MBA (Pharm)

Siva Kumar Pulla is a market expert specializing in aortic repair devices within the Cardiovascular Medtech Insights team at Decision Resources Group. Siva holds a Bachelor's degree in Pharmaceutical Sciences from Jawaharlal Nehru Technological University and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Hyderabad.